Alberta Gazette — 14 June (ii)
0614 ii
Alberta — Gazette
Alberta Regulation 139/2003
Traffic Safety Act
VEHICLE SEIZURE AND REMOVAL AMENDMENT REGULATION
Filed: May 16, 2003
Made by the Minister of Transportation (M.O. 24/03) on May 15, 2003
pursuant to sections 18(2) and 81 of the Traffic Safety Act.
1 The Vehicle Seizure and Removal Regulation (AR 323/2002) is amended by
this Regulation.
Section 5(2) is amended in clause (
c) by adding "where the vehicle is
immobilized under
section 173 of the Act," before "provide".
Section 6(2) is amended in clause (
e) by adding "where the vehicle is
seized or removed under
section 173 of the Act," before "provide".
Section 12 is amended
(
a) by repealing subsection (2) and substituting the following:
(2) If an abandoned vehicle is not claimed by the owner under
subsection (1), the Administrator must send a notice containing the
information described in subsection (3) by ordinary mail to the owner at
the latest physical or postal address for the owner as shown in the records
of the Registrar.
(
b) in subsection (3)
(
a) in clause (
b) by striking out "retrieved" and
substituting "claimed";
(
b) by adding "and" at the end of clause (
c) and by
repealing clause (d).
Section 13(2)(
b) and (3)(
b) is amended by striking out "retrieved" and
substituting "claimed".
Section 14(2) is amended
(
a) by striking out "or" at the end of clause (a);
(
b) by adding the following after clause (a):
(a.1) within 30 days after the vehicle is released from
seizure or removal, unless clause (
b) applies, or
(
c) by repealing clause (
b) and substituting the following:
(
b) in the case of an abandoned vehicle in respect of
which notification has been given under
section 12(2), within 15 days after
the Administrator gives notification under
section 12(2).
Section 14(2)(a.1) is repealed.
Section 22 is amended
(
a) by renumbering it as
section 22(1);
(
b) in subsection (1), by striking out "This" and substituting
"Subject to subsection (2), this";
(
c) by adding the following after subsection (1):
(2) Sections 13 and 14(2)(
a) come into force on June 1,
Section 7 comes into force on June 1, 2004.
------------------------------
Alberta Regulation 140/2003
Traffic Safety Act
ACCESS TO MOTOR VEHICLE INFORMATION REGULATION
Filed: May 20, 2003
Made by the Lieutenant Governor in Council (O.C. 248/2003) on May 20, 2003
pursuant to
section 8 of the Traffic Safety Act.
Table of Contents
Definitions 1
Release of information 2
Agreement 3
Notification 4
Driver's abstract 5
Release of information 6
Repeal 7
Expiry 8
Coming into force 9
Definitions
1 In this Regulation,
(a) "Act" means the Traffic Safety Act;
(b) "Commissioner" means Commissioner as defined in the Freedom of
Information and Protection of Privacy Act;
(c) "information" means personal driving and motor vehicle
information as defined in the Act;
(d) "law enforcement" means law enforcement as defined in the
Freedom of Information and Protection of Privacy Act;
(e) "public body" means a public body as defined in the Freedom of
Information and Protection of Privacy Act.
Release of information
2(1) The Registrar may, on request, release information,
(
a) on the Registrar's motor vehicle information system, collected
and compiled for the purpose of identifying licensed operators and
registered owners of motor vehicles to ensure responsibility and
accountability for their actions with respect to motor vehicles, only for
that purpose or for a use consistent with that purpose,
(
b) only for the purpose of complying with an enactment of Alberta
or Canada or with a treaty, arrangement or agreement made under an
enactment of Alberta or Canada,
(
c) only for any purpose in accordance with an enactment of Alberta
or Canada that authorizes or requires the release,
(
d) only for the purpose of complying with a subpoena, warrant or
order issued or made by a court, person or body having jurisdiction to
compel the production of information or with a rule of court that relates
to the production of information,
(
e) only to an officer or employee of a public body, the Registrar,
an agent of the Registrar or to a member of the Executive Council, if the
information is necessary for the performance of the duties of the officer,
employee or member or if the disclosure is necessary for the delivery of a
program or service,
(
f) only for the purpose of enforcing a legal right that the
Government of Alberta or a public body has against any person,
(
g) only for the purpose of
(
i) collecting a fine or debt owing by an individual to
the Government of Alberta or to a public body, or to an assignee of either
of them, or
(ii) making a payment owing by the Government of Alberta
or by a public body to an individual,
(
h) only for the purpose of determining or verifying an
individual's suitability or eligibility for a program or benefit offered by
a public body pursuant to an enactment, if the individual has applied for
the program or benefit,
(
i) only to the Auditor General, an employee of a public body or a
person under contract with a public body for audit purposes,
(
j) only to a public body or a law enforcement agency in Canada to
assist in an investigation
(
i) undertaken with a view to a law enforcement
proceeding, or
(ii) from which a law enforcement proceeding is likely
to result,
(
k) only so that the spouse, relative or friend of a deceased or
severely injured or ill individual may be contacted, if the Registrar is
satisfied that the circumstances warrant the release of the information,
(
l) only for research purposes, including statistical research,
only if
(
i) the research purpose cannot reasonably be
accomplished unless that information is released in individually
identifiable form,
(ii) any record linkage is not harmful, as determined by
the Registrar, to the individuals the information is about and the benefits
to be derived from the record linkage are clearly in the public interest,
and
(iii) the person to whom the information is disclosed has
signed an agreement pursuant to
section 3,
(
m) only to a person for use in or for the purposes of, a
proceeding before a court or quasi-judicial body,
(
n) only to the Chief Electoral Officer, if the information is
necessary for the performance of the duties of the Chief Electoral Officer,
(
o) only if the Registrar believes, on reasonable grounds, that the
release will avert or minimize an imminent danger to the health or safety
of any person, or
(
p) only if the individual the information is about has consented
to its release in accordance with subsection (3).
(2) The request for information and the release of information referred to
in subsection (1) must be in a form and manner satisfactory to the
Registrar.
(3) For the purposes of subsection (1)(p), the consent of an individual to
the release of that individual's information
(
a) must be in writing and signed by the individual,
(
b) must identify the information to be released, and
(
c) must specify to whom the information may be released and for
what purpose the information may be used.
(4) Despite subsection (3), consent for the purposes of subsection (1)(
p) may be given
(
a) if the individual is deceased, by the individual's executor or
administrator if the information is to be used in the administration of the
individual's estate,
(
b) if there is a guardian or trustee appointed for the individual
under the Dependent Adults Act, by the guardian or trustee of the
individual if the information is to be used in the carrying out of the
powers or duties of the guardian or trustee,
(
c) if a power of attorney has been granted by the individual, by
the individual's attorney if the information is to be used in the carrying
out of the powers or duties granted in the power of attorney, or
(
d) if the individual is a minor, by the parent or guardian of the
minor.
(5) Despite subsection (1), the Registrar may release the names and
addresses of licensed operators in Alberta to the War Amputations of Canada
without the consent of the licensed operators until May 20, 2006.
Agreement
3(1) Before releasing any information pursuant to
section 2, the
Registrar, or any person acting on behalf of the Registrar, must ensure
that the person to whom the information is to be released enters into an
agreement with the Registrar in accordance with this section.
(2) The form of the agreement referred to in subsection (1) must be
satisfactory to the Registrar, and must specify that
(
a) the applicant must not use or release the information except
for the purpose for which it was requested, and
(
b) the applicant shall not contravene
(
i) any information management policies as set out in
the agreement, including those respecting the retention and destruction of
the information, and
(ii) any requirements as set out in the agreement
respecting audits by the Registrar for compliance with agreements or of the
applicant's information management practices.
(3) The Registrar may refuse to release information to the recipient if,
in the Registrar's opinion, the recipient has contravened subsection (2).
Notification
4(1) Before releasing any information pursuant to a request under
section
2, the Registrar must publish a notification
(
a) on the Registrar's website maintained on the Government of
Alberta, Department of Government Services website,
(
b) of the category of information to be or not to be released by
the Registrar and the person or category of persons to whom the Registrar
is or is not to release the information,
(
c) that states that, on request by a person, information may or
may not be released in accordance with clause (
b) for the purposes set out
in this Regulation, and
(
d) that includes the date of the publication and a statement that
any person may, within 60 days after the date of publication under this
subsection, ask the Commissioner to review the decision of the Registrar in
accordance with
Part 5, Division 1.1 of the Freedom of Information and
Protection of Privacy Act.
(2) The Registrar may release information to a person who requested the
information before the expiry of the 60-day period referred to in
subsection (1)(d), if the Registrar was providing information to that
person prior to May 1, 2004.
(3) On the issuance of the notification in accordance with subsection (1),
notice is deemed to have been given for the current and any future releases
of the category of information and of the person or category of persons to
whom the information is released or not released, as described in the
notification, for the purposes of notice under
Part 5, Division 1.1 of the
Freedom of Information and Protection of Privacy Act.
(4) On the coming into force of any amendments to
section 2, a new
notification must be issued in respect of any request for information
pursuant to those amendments in accordance with subsection (1).
Driver's abstract
5(1) The Registrar, on request,
(
a) must release an abstract of the driving record of a person to
that person,
(
b) may release an abstract of the driving record of a person
(
i) for the 3-year period or a greater period preceding
the request as permitted by the Registrar, to an insurer or surety, if
(
A) the abstract is required for the
purposes of determining whether to grant or maintain motor vehicle
insurance in respect of that person, and
(
B) the insurer or surety has obtained the
consent of that person in accordance with subsection (2),
(ii) to a peace officer,
(iii) to an employer or prospective employer of that
person if the employer or prospective employer has a written authorization
from that person authorizing the abstract to be released to the employer or
prospective employer,
(iv) to a parent or guardian of that person if, under
the law, that person requires the signature of that parent or guardian on
that person's operator's licence application, or
(
v) to a lawyer of that person if the lawyer has a
written authorization from that person authorizing the abstract to be
released to that lawyer,
and
(
c) must release to a person who is injured or whose property is
damaged by a motor vehicle, or to that person's personal representative if
that person is killed by a motor vehicle, any information on the
Government's records pertaining to the proof of financial responsibility of
any owner or driver of the motor vehicle.
(2) For the purposes of subsection (1)(b)(i)(B), consent may be given in
writing, electronically or orally, if the Registrar has approved the manner
by which consent is given to the insurer or surety.
Release of information
6 The Registrar may, on request by any person, release information
including, but not restricted to information referred to in
section 5.
Repeal
Section 6 is repealed.
Expiry
8 For the purpose of ensuring that this Regulation is reviewed for
ongoing relevancy and necessity, with the option that it may be repassed in
its present or an amended form following a review, this Regulation expires
on April 30, 2013.
Coming into force
9 This Regulation, except for sections 1, 5 and 6, comes into force on
May 1, 2004.
------------------------------
Alberta Regulation 141/2003
Adult Interdependent Relationships Act
ADULT INTERDEPENDENT PARTNER AGREEMENT REGULATION
Filed: May 20, 2003
Made by the Minister of Justice and Attorney General (M.O. 16/2003) on May
16, 2003 pursuant to
section 13 of the Adult Interdependent Relationships
Act.
Form of agreement
1 An adult interdependent partner agreement under
section 7 of the Act
must be in the form set out in the Schedule.
Expiry
2 For the purpose of ensuring that this Regulation is reviewed for
ongoing relevancy and necessity, with the option that it may be repassed in
its present or an amended form following a review, this Regulation expires
on June 30, 2012.
Coming into force
3 This Regulation comes into force on the coming into force of
section 3
of the Adult Interdependent Relationships Act.
Schedule
Adult Interdependent Partner Agreement
BETWEEN: (Name and address of adult interdependent partner)
and
(Name and address of adult interdependent partner)
We understand that by entering into this Agreement we will become each
other's adult interdependent partner and will have all the benefits and
obligations of adult interdependent partners under Alberta law.
1 We agree that
(
a) each of us is 16 years of age or older,
(
b) neither of us is a party to an ongoing marriage or adult
interdependent partner agreement, and
(
c) we are living or intend to live together in a relationship of
interdependence.
2 We understand that
(
a) pursuant to the Wills Act, each of our existing wills may be
revoked by the entering into of this Agreement, and
(
b) this Agreement will expire if we become former adult
interdependent partners pursuant to the Adult Interdependent Relationships
Act.
In witness whereof we have executed this Agreement in the (city, town,
county) of (province, state, country) this day of
, 20 .
Witness
(Print Name and Address)
Adult Interdependent Partner
Witness
(Print Name and Address)
Witness
(Print Name and Address)
Adult Interdependent Partner
Witness
(Print Name and Address)
Guardians' signatures (if applicable):
Date: Date:
Guardian Guardian
(Print name) (Print name)
NOTES:
1. Each adult interdependent partner's signature must be witnessed by 2
witnesses.
2. If either adult interdependent partner is under the age of 18 years,
the guardians of that person must sign above indicating their consent to
the person entering into the Adult Interdependent Partner Agreement.
3. A person who is under the age of 18 years may not enter into an Adult
Interdependent Partner Agreement if the person is related to the other
party by blood or adoption.
4. An Adult Interdependent Partner Agreement may be part of or attached
to another agreement between the parties.
5. If an Adult Interdependent Partner Agreement is part of or attached
to another agreement between the parties that contains one or more
provisions relating to the property of one or both of the parties, the
parties are advised to seek legal advice as to their rights and obligations
in respect of that property.
------------------------------
Alberta Regulation 142/2003
Cemeteries Act
GENERAL AMENDMENT REGULATION
Filed: May 21, 2003
Made by the Minister of Government Services (M.O. C:008/2003) on May 15,
2003 pursuant to
section 65(1) of the Cemeteries Act.
1 The General Regulation (AR 249/98) is amended by this Regulation.
Section 11 is amended
(
a) by repealing subsection (1)(a)(
i) and (ii) and substituting the
following:
(
i) the deceased resided before death in a care
facility for health reasons and the spouse or adult interdependent partner
continued to provide the usual support customarily associated with couples
intending to continue a relationship, or
(ii) the deceased and the spouse or adult interdependent
partner were living apart at the time of death due only to circumstances
other than a breakdown of their relationship;
(
b) by repealing subsection (2)(
b) and substituting the following:
(
b) the spouse or adult interdependent partner of the
deceased if the spouse or adult interdependent partner was living with the
deceased at the time of death;
3 This Regulation comes into force on June 1, 2003.
------------------------------
Alberta Regulation 143/2003
Fair Trading Act
COST OF CREDIT DISCLOSURE AMENDMENT REGULATION
Filed: May 21, 2003
Made by the Minister of Government Services (M.O. C:005/2003) on May 15,
2003 pursuant to
section 101(1) of the Fair Trading Act.
1 The Cost of Credit Disclosure Regulation (AR 198/99) is amended by this
Regulation.
Section 1(1)(
a) is amended by adding "or adult interdependent partner"
after "the spouse".
Section 1(3) is amended by adding the following after clause (b):
(c) "spouse" means the husband or wife of a married person but does
not include a spouse who is living separate and apart from the person if
the person and spouse have separated pursuant to a written separation
agreement or if their support obligations and family property have been
dealt with by a court order.
4 This Regulation comes into force on June 1, 2003.
Alberta Regulation 144/2003
Fair Trading Act
CREDIT AND PERSONAL REPORTS AMENDMENT REGULATION
Filed: May 21, 2003
Made by the Minister of Government Services (M.O. C:004/2003) on May 15,
2003 pursuant to sections 51 and 162(2) of the Fair Trading Act.
1 The Credit and Personal Reports Regulation (AR 193/99) is amended by
this Regulation.
Section 1 is repealed.
Section 4(
c) is amended by adding "or adult interdependent partner"
after "spouse".
4 This Regulation comes into force on June 1, 2003.
------------------------------
Alberta Regulation 145/2003
Funeral Services Act
GENERAL AMENDMENT REGULATION
Filed: May 21, 2003
Made by the Minister of Government Services (M.O. C:006/2003) on May 15,
2003 pursuant to
section 27(1)(
c) of the Funeral Services Act.
1 The General Regulation (AR 226/98) is amended by this Regulation.
Section 36 is amended
(
a) by repealing subsection (1)(a)(
i) and (ii) and substituting the
following:
(
i) the deceased resided before death in a care
facility for health reasons and the spouse or adult interdependent partner
continued to provide the usual support customarily associated with couples
intending to continue a relationship, or
(ii) the deceased and the spouse or adult interdependent
partner were living apart at the time of death due only to circumstances
other than a breakdown of their relationship;
(
b) by repealing subsection (2)(
b) and substituting the following:
(
b) the spouse or adult interdependent partner of the
deceased if the spouse or adult interdependent partner was living with the
deceased at the time of death;
3 This Regulation comes into force on June 1, 2003.
------------------------------
Alberta Regulation 146/2003
Mobile Home Sites Tenancies Act
MOBILE HOME SITES TENANCIES MINISTERIAL
AMENDMENT REGULATION
Filed: May 21, 2003
Made by the Minister of Government Services (M.O. C:003/2003) on May 15,
2003 pursuant to
section 66 of the Mobile Home Sites Tenancies Act.
1 The Mobile Home Sites Tenancies Ministerial Regulation (AR 54/96) is
amended by this Regulation.
Section 2(1) is amended by striking out "affinity" and substituting
"blood, marriage or adoption or by virtue of an adult interdependent
relationship".
3 This Regulation comes into force on June 1, 2003.
Alberta Regulation 147/2003
Residential Tenancies Act
RESIDENTIAL TENANCIES MINISTERIAL AMENDMENT REGULATION
Filed: May 21, 2003
Made by the Minister of Government Services (M.O. C:007/2003) on May 15,
2003 pursuant to
section 64 of the Residential Tenancies Act.
1 The Residential Tenancies Ministerial Regulation (AR 229/92) is amended
by this Regulation.
Section 2(1)(
b) is amended by striking out "affinity" and substituting
"blood, marriage or adoption or by virtue of an adult interdependent
relationship".
3 This Regulation comes into force on June 1, 2003.
------------------------------
Alberta Regulation 148/2003
Traffic Safety Act
OFF-HIGHWAY VEHICLE AMENDMENT REGULATION
Filed: May 21, 2003
Made by the Minister of Transportation (M.O. 19/03) on May 13, 2003
pursuant to
section 129 of the Traffic Safety Act.
1 The Off-highway Vehicle Regulation (AR 319/2002) is amended by this
Regulation.
Section 14 is amended
(
a) in subsection (1)(
c) by adding "or is an adult interdependent
partner" after "married";
(
b) in subsection (4)(
c) by adding "or was not an adult
interdependent partner" after "married".
3 This Regulation comes into force on June 1, 2003.
Alberta Regulation 149/2003
Traffic Safety Act
OPERATOR LICENSING AND VEHICLE CONTROL
AMENDMENT REGULATION
Filed: May 21, 2003
Made by the Minister of Transportation (M.O. 20/03) on May 13, 2003
pursuant to sections 18(2), 64, 81, 100 and 116 of the Traffic Safety Act.
1 The Operator Licensing and Vehicle Control Regulation (AR 320/2002) is
amended by this Regulation.
Section 12 is amended
(
a) in subsection (1)(
c) by adding "or is an adult interdependent
partner" after "married";
(
b) in subsection (3)(
c) by adding "or was not an adult
interdependent partner" after "married".
Section 55 is amended
(
a) in subsection (1)(
c) by adding "or is an adult interdependent
partner" after "married";
(
b) in subsection (4)(
c) by adding "or was not an adult
interdependent partner" after "married".
Section 83(
a) is amended by adding "or adult interdependent partner"
after "spouse" wherever it occurs.
5 This Regulation comes into force on June 1, 2003.
Alberta Regulation 150/2003
Agricultural Pests Act
PEST AND NUISANCE CONTROL AMENDMENT REGULATION
Filed: May 22, 2003
Made by the Minister of Agriculture, Food and Rural Development (M.O.
18/2003) on May 15, 2003 pursuant to
section 2 of the Agricultural Pests
Act.
1 The Pest and Nuisance Control Regulation (AR 184/2001) is amended by
this Regulation.
Section 2 is amended by renumbering it as
section 2(1) and by adding
the following after subsection (1):
(2) Wild boar (Sus scrofa) when at large in Lac Ste. Anne County is
declared to be a pest.
------------------------------
Alberta Regulation 151/2003
Municipal Government Act
SMOKY RIVER REGIONAL WATER MANAGEMENT
COMMISSION REGULATION
Filed: May 28, 2003
Made by the Lieutenant Governor in Council (O.C. 250/2003) on May 28, 2003
pursuant to
section 602.02 of the Municipal Government Act.
Table of Contents
Establishment 1
Members 2
Water supply system 3
Operating deficits 4
Sale of property 5
Profit and surpluses 6
Approval 7
Establishment
1 A regional services commission known as the Smoky River Regional Water
Management Commission is established.
Members
2 The following municipalities are members of the Commission:
(
a) Municipal District of Smoky River No. 130;
(
b) Town of Falher;
(
c) Town of McLennan;
(
d) Village of Donnelly;
(
e) Village of Girouxville.
Water supply system
3 The Commission is authorized to provide and operate a water supply
system.
Operating deficits
4 The Commission may not assume operating deficits that are shown on the
books of any of the member municipalities.
Sale of property
5(1) The Commission may not, without the approval of the Minister, sell
any of its land, buildings, equipment or inventory whose purchase has been
funded wholly or partly by grants from the Government of Alberta.
(2) The Minister may not approve a sale under subsection (1) unless the
Minister is satisfied
(
a) as to the repayment of the grants from the Government of
Alberta and outstanding debt associated with that portion of the land,
buildings, equipment or inventory to be sold,
(
b) that the sale would not have a significant adverse effect on
the services the Commission provides, and
(
c) that the sale will be properly reflected in the rates
subsequently charged to the customers of the Commission.
Profit and surpluses
6 Unless otherwise approved by the Minister, the Commission may not
(
a) operate for the purposes of making a profit, or
(
b) distribute any of its surpluses to its member municipalities.
Approval
7 The Minister may make an approval under
section 5 or 6 subject to any
terms or conditions the Minister considers appropriate.
Alberta Regulation 152/2003
Municipal Government Act
AQUATERA UTILITIES INC. REGULATION
Filed: May 28, 2003
Made by the Lieutenant Governor in Council (O.C. 251/2003) on May 28, 2003
pursuant to
section 603 of the Municipal Government Act.
Table of Contents
Definitions 1
Application of Act 2
Exemption from Public Utilities Board Act 3
Dispute resolution 4
Provision of extra-provincial services 5
Repeal 6
Definitions
1 In this Regulation,
(a) "Act" means the Municipal Government Act;
(b) "public utility" means a system or works used to provide water,
sewage disposal or solid waste management for public consumption, benefit,
convenience or use.
Application of Act
2(1) Subject to subsection (2), sections 43 to 47 of the Act apply in
respect of a utility service provided by Aquatera Utilities Inc.
(2) Section 45(3)(
b) of the Act does not apply in respect of a public
utility owned or operated by Aquatera Utilities Inc.
Exemption from Public Utilities Board Act
Part 2 of the Public Utilities Board Act does not apply in respect of a
public utility that
(
a) is owned or operated by Aquatera Utilities Inc., and
(
b) provides a utility service within the boundaries of those
municipalities that are shareholders of Aquatera Utilities Inc.
Dispute resolution
4 If there is a dispute between a regional services commission and
Aquatera Utilities Inc. with respect to
(
a) rates, tolls or charges for a service that is a public utility,
(
b) compensation for the acquisition by the commission of
facilities used to provide a service that is a public utility, or
(
c) the commission's use of any road, square, bridge, subway or
watercourse to provide a service that is a public utility,
any party involved in the dispute may submit it to the Public Utilities
Board, and the Public Utilities Board may issue an order on any terms and
conditions that the Public Utilities Board considers appropriate.
Provision of extra-provincial services
5 Aquatera Utilities Inc. shall not provide any utility services outside
of Alberta without the prior written approval of the Minister.
Repeal
6 This Regulation is repealed in accordance with
section 603(2) of the
Act.
------------------------------
Alberta Regulation 153/2003
Cancer Programs Act
CANCER PROGRAMS AMENDMENT REGULATION
Filed: May 28, 2003
Made by the Minister of Health and Wellness (M.O. 57/2003) on May 22, 2003
pursuant to sections 16 and 22 of the Cancer Programs Act.
1 The Cancer Programs Regulation (AR 242/98) is amended by this
Regulation.
2 The
Schedule is repealed and the following is substituted:
SCHEDULE
Drug
Group
Dosage Form
Criteria
13 Cis-RETINOIC ACID
capsules
Pediatrics
restricted to the treatment of advanced stage neuroblastoma following
POG/CCG Protocols
prescribing limited to written authorization by physicians recommended by
the pediatric tumour program
ALL-TRANS RETINOIC ACID
capsules
restricted to treatment of acute promyelocytic leukemia
prescribing limited to written authorization by physicians recommended by
the hematology/lymphoma tumour program or the pediatric tumour program
AMSACRINE
injectable
ANAGRELIDE
capsules
for thrombocytosis due to myeloproliferative disorder
prescribing limited to written authorization by physicians recommended by
the hematology/lymphoma tumour program
ANASTROZOLE
tablets
for post-menopausal patients with receptor-positive, metastatic breast
cancer who have progressed or have experienced severe side effects on prior
hormone therapy
tablets
for adjuvant use in invasive breast cancer patients who are
post-menopausal, hormone receptor positive and are at risk of a
thromboembolic event. Risk is defined as a personal history of a previous
thromboembolic event either while on tamoxifen or otherwise
prescribing limited to written authorization by named physicians as
recommended by the breast tumour program
ASPARAGINASE
injectable
BCG
injectable
bladder carcinoma
BICALUTAMIDE
tablets
restricted to patients who are intolerant to Nilutamide or Flutamide
approved dosage is 50 mg daily
BLEOMYCIN
injectable
pump
BUSERELIN
injectable
prostate cancer
Restricted to:
Stage II (T2a-T2c): Neoadjuvant use pre RT (2 months pre and during RT).
Neoadjuvant use pre radical prostatectomy (4 months pre)
Stage III (T3a-T4b): Neoadjuvant use pre RT (2 months pre and during RT).
Adjuvant use (3 years post RT)
Stage IV (N1-N3) (M1-M1c): As monotherpy in medical castration.
In total androgen blockade (medical castration and nonsteriodal
antiandrogen)
Guidelines for LHRH use in the above stated stages include: LHRH agonists
are indicated for use in patients at risk of thromboembolic disease,
strokes (CVA), myocardial infarction and also for consideration in patients
with dyslipidemia, hypertension, diabetes mellitus or where a patient is
considered intolerant to cyproterone acetate or megestrol acetate
BUSULFAN
tablets
CAPECITABINE
oral
for use in anthracycline pretreated metastatic or advanced breast cancer
patients who may or may not have been previously treated with taxanes
prescribing limited to written authorization by physicians recommended by
the breast tumour program
oral
option in first line treatment of advanced or metastatic colorectal
cancer
prescribing limited to written authorization by named physicians as
recommended by the GI tumour program
CARBOPLATIN
injectable
CARMUSTINE
injectable, topical
CHLORAMBUCIL
tablets
CISPLATIN
injectable
CLADRIBINE
injectable
restricted to treatment of hairy cell leukemia
Waldenstrom's macroglobulinemia
hematologic malignancies (histocytosis-X, cutaneous T-cell lymphoma,
systemic mast cell disease)
prescribing limited to written authorization by physicians recommended by
the hematology/lymphoma tumour program
injectable
POG Protocol 9720
prescribing limited to written authorization by physicians recommended by
the pediatric tumour program
CLODRONATE
oral
treatment of osteolytic bone lesions in metastatic breast cancer
CYCLOPHOSPHAMIDE
injectable, tablets
CYPROTERONE
tablets
CYTARABINE
injectable
CYTARABINE LIPOSOMAL
injectable
for intrathecal management of neoplastic meningitis due to solid tumours
or lymphoma
DACARBAZINE
injectable
DACTINOMYCIN
injectable
DAUNORUBICIN
injectable
DEXAMETHASONE
injectable, tablets
antiemetic use NOT covered
DOCETAXEL
injectable
treatment of metastatic breast cancer after failure of any previous
chemotherapy regimen
as a single agent or in combination, as an option for first line
treatment of metastatic breast cancer
only one taxane is to be administered to any one patient
prescribing limited to written authorization by named physicians as
recommended by the breast tumour program
injectable
Breast Neoadjuvant
following a neoadjuvant anthracycline containing regimen in locally
advanced (Stage IIIA or IIIB) breast cancer
prescribing limited to written authorization by named physicians as
recommended by the breast tumour program
injectable
Breast Adjuvant
(with doxorubicin and cyclophosphamide (TAC)) as an adjuvant treatment of
1-3 node positive breast cancer
prescribing limited to written authorization by named physicians as
recommended by the breast tumour program
injectable
2nd line therapy in patients with advanced or metastatic non-small cell
lung cancer with good performance status (ECOG 0-2) and no symptomatic or
uncontrolled brain metastases
prescribing limited to written authorization by named physicians as
recommended by the lung tumour program
DOXORUBICIN
injectable
DOXORUBICIN LIPOSOMAL
injectable
Kaposi's sarcoma
injectable
2nd or 3rd line treatment of ovarian cancer, fallopian tube carcinoma and
primary peritoneal neoplasms
prescribing limited to written authorization by named physicians as
recommended by the gynecology tumour program
EPIRUBICIN
injectable
Breast Cancer
adjuvant (node positive) and neoadjuvant (stage II and III) treatment of
pre and post-menopausal breast cancer patients
prescribing limited to written authorization by named physicians as
recommended by the breast tumour program
injectable
Esophagogastric Cancer
used (in combination with cisplatin and fluorouracil) in the treatment of
locally advanced or metastatic esophagogastric cancer in patients with good
performance status
ERWINIA ASPARAGINASE
injectable
restricted to use in patients hypersensitive to E. Coli asparaginase for
remission induction in acute lymphoblastic leukemia
prescribing limited to written authorization by physicians recommended by
the pediatric tumour program or the hematology/ lymphoma program
ESTRAMUSTINE
capsules
ETOPOSIDE
injectable, capsules
EXEMESTANE
oral
for hormonal treatment of advanced breast cancer in post-menopausal women
who have progressed following hormonal therapy
prescribing limited to written authorization by named physicians as
recommended by the breast tumour program
FLUDARABINE
injectable, tablets
previously treated or untreated chronic lymphocytic leukemia
low grade lymphoma
Waldenstrom's macroglobulinemia
prescribing limited to written authorization by physicians recommended by
the hematology tumour program
FLUOROURACIL
injectable, cream
pump
FLUTAMIDE
tablets
prostate cancer
GEMCITABINE
injectable
Non-small Cell Lung Cancer
patients who are unable to tolerate vinorelbine or paclitaxel containing
regimens with documented reason for intolerance
prescribing limited to written authorization by physicians recommended by
the lung tumour program
injectable
Bladder Cancer
Gemcitabine/Cisplatin as first line chemotherapy in locally
advanced/metastatic bladder cancer
prescribing limited to written authorization by physicians recommended by
the GU tumour program
injectable
Pancreas
locally advanced or metastatic adenocarcinoma of the pancreas
prescribing limited to written authorization by physicians recommended by
the GI tumour program
GOSERELIN
injectable
prostate cancer
Restricted to:
Stage II (T2a-T2c): Neoadjuvant use pre RT (2 months pre and during RT).
Neoadjuvant use pre radical prostatectomy (4 months pre)
Stage III (T3a-T4b): Neoadjuvant use pre RT (2 months pre and during RT).
Adjuvant use (3 years post RT)
Stage IV (N1-N3) (M1-M1c): As monotherpy in medical castration
In total androgen blockade (medical castration and nonsteriodal
antiandrogen)
Guidelines for LHRH use in the above stated stages include: LHRH agonists
are indicated for use in patients at risk of thromboembolic disease,
strokes (CVA), myocardial infarction and also for consideration in patients
with dyslipidemia, hypertension, diabetes mellitus or where a patient is
considered intolerant to cyproterone acetate or megestrol acetate
injectable
breast cancer. 2nd line hormonal therapy for recurrent or metastatic
disease in either or both estrogen and progesterone receptor positive pre
and perimenopausal patients after tamoxifen failure
prescribing limited to written authorization by physicians recommended by
the breast tumour program
HYDROCORTISONE SODIUM SUCCINATE
injectable
intrathecal use only
HYDROXYUREA
capsules
IDARUBICIN
injectable
POG Protocol 9720
prescribing limited to written authorization by physicians recommended by
the pediatric tumour program
IFOSFAMIDE
injectable
pump
IMATINIB
capsules
for surgically unresectable or metastatic gastrointestinal stromal tumour
(GIST)
prescribing limited to written authorization by named physicians as
recommended by the tumour program
capsules
non-bone marrow transplant candidates (by virtue of age over 60,
co-morbid illnesses or no HLA matched donor available) who have chronic
phase CML
patients who are non-transplant candidates and who have accelerated phase
or blast crisis phase CML
patients with hematological or cytogenetic relapse following autologous
or allogeneic stem cell transplantation
prescribing limited to written authorization by named physicians as
recommended by the hematology/lymphoma tumour program
INTERFERON
- alpha 2a or 2b
- alpha 2b in new patients "03-04"
injectable
cladribine-resistant hairy cell leukemia
Kaposi's sarcoma
chronic myelogenous leukemia
metastatic renal cell carcinoma
INTERFERON
alpha 2a ONLY
injectable
mycosis fungoides and sezary syndrome (cutaneous T-cell lymphomas)
prescribing limited to written authorization by physicians recommended by
the hematology/lymphoma tumour program
INTERFERON
alpha 2b ONLY
injectable
basal cell carcinoma
adjuvant treatment of high risk melanoma
2nd line therapy of superficial bladder cancer or first line in those
with a documented intolerance or contraindication (i.e., immunosuppression
or other) to BCG
injectable
treatment of patients with malignant carcinoid and neuroendocrine
gastroenteropancreatic tumours not amenable to surgical extirpation
prescribing limited to written authorization by physicians recommended by
the GI and endocrine tumour programs
injectable
maintenance therapy in multiple myeloma patients who have achieved
complete remission after high dose chemotherapy and autologous stem cell
transplant
follicular lymphoma and need for therapy as indicated by any of: mass >7
cm or 3 sites >3 cm, Bsx, splenomegaly @ umbilicus, compression syndromes
(GI, GU, orbit), effusions cytopenias, Age